Posts

Posted on

Liver ablation articles

  1. Young, S, Abramyan, A, Goldberg, D, Hannallah, J, Schaub, D, Kalarn, S et al.. Correction to: Cryoablation in the liver: how accurately does the iceball predict the ablation zone?. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-025-05026-3. PubMed PMID:40493179 .
  2. Zha, J, Zhang, F, Cao, T, Li, S, Shen, X, Xu, L et al.. Efficacy and safety of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma at specific anatomic sites of the liver: a systematic review and meta-analysis. Front Surg. 2025;12 :1587435. doi: 10.3389/fsurg.2025.1587435. PubMed PMID:40476052 PubMed Central PMC12137246.
  3. Peng, Y, Yang, P, Zeng, X, Hu, Z, Luo, H, Wang, D et al.. Letter to the editor: comment on "liver resection versus radiofrequency ablation for solitary small hepatocellular carcinoma measuring≤3cm: a systematic review and meta-analysis.". Int J Surg. 2025; :. doi: 10.1097/JS9.0000000000002616. PubMed PMID:40474811 .
  4. Yu, K, Huang, Y, Wang, Y, Wu, Q, Wang, Z, Li, F et al.. Correction: PEGylated gas vesicles: a promising novel ultrasound contrast agent for diagnosis and guiding radiofrequency ablation of liver tumor. J Nanobiotechnology. 2025;23 (1):394. doi: 10.1186/s12951-025-03491-y. PubMed PMID:40448238 PubMed Central PMC12124017.
  5. Huang, L, Qi, E, Liu, Z, Zhang, Q, Wang, S, Zheng, S et al.. Beyond thermal protection: Injectable self-healing chitosan hydrogel in liver tumor thermal ablation. Int J Biol Macromol. 2025;313 :144187. doi: 10.1016/j.ijbiomac.2025.144187. PubMed PMID:40379161 .
  6. Yu, K, Huang, Y, Wang, Y, Wu, Q, Wang, Z, Li, F et al.. PEGylated gas vesicles: a promising novel ultrasound contrast agent for diagnosis and guiding radiofrequency ablation of liver tumor. J Nanobiotechnology. 2025;23 (1):344. doi: 10.1186/s12951-025-03377-z. PubMed PMID:40369524 PubMed Central PMC12076873.
  7. Zhang, H, Chen, X, Lu, T, Cao, Q, Li, X. Selenoprotein S ablation-mediated pyroptosis contributes to liver damage resulting from selenium deficiency in chickens. Poult Sci. 2025;104 (8):105269. doi: 10.1016/j.psj.2025.105269. PubMed PMID:40367564 PubMed Central PMC12142317.
  8. Giannone, F, Sangiuolo, F, Cassese, G, Palucci, M, Del Basso, C, Lapergola, A et al.. The Impact of KRAS Status on Long-Term Outcomes After Thermal Ablation and Hepatic Resection for Liver-Only Colorectal Metastases: A New Clue for Tailoring Surgical Strategy on Tumor Biology?. World J Surg. 2025;49 (6):1573-1582. doi: 10.1002/wjs.12616. PubMed PMID:40344254 PubMed Central PMC12134197.
  9. Yang, J, Song, Y, Geng, J, Zhao, J, Xiao, B, Zhao, H et al.. Immediate changes in MRI signals after the MRI-guided microwave ablation of malignant liver tumors. J Cancer Res Ther. 2025;21 (2):435-441. doi: 10.4103/jcrt.jcrt_1458_24. PubMed PMID:40317149 .
  10. Paolucci, I, Albuquerque Marques Silva, J, Lin, YM, Shieh, A, Ierardi, AM, Caraffiello, G et al.. Quantitative Ablation Confirmation Methods in Percutaneous Thermal Ablation of Malignant Liver Tumors: Technical Insights, Clinical Evidence, and Future Outlook. Radiol Imaging Cancer. 2025;7 (3):e240293. doi: 10.1148/rycan.240293. PubMed PMID:40314585 PubMed Central PMC12130695.
  11. Yu, JW, Zhao, Q, Li, PX, Zhang, YX, Gao, BX, Xiang, LB et al.. Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease. World J Gastroenterol. 2025;31 (16):105188. doi: 10.3748/wjg.v31.i16.105188. PubMed PMID:40308802 PubMed Central PMC12038522.
  12. Ren, H, Chen, J, Wu, Z, Li, C. Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation. Front Oncol. 2025;15 :1566865. doi: 10.3389/fonc.2025.1566865. PubMed PMID:40308490 PubMed Central PMC12040659.
  13. Tombesi, P, Cutini, A, Di Vece, F, Grasso, V, Politti, U, Capatti, E et al.. Surgery or Percutaneous Ablation for Liver Tumors? The Key Points Are: When, Where, and How Large. Cancers (Basel). 2025;17 (8):. doi: 10.3390/cancers17081344. PubMed PMID:40282520 PubMed Central PMC12025409.
  14. Ashkar, A, Kübler, J, Nikolaou, K, Hoffmann, R, Winkelmann, MT. Evaluating Pre-Interventional Administration of a Liver-Specific Contrast Agent During MRI-Guided Thermal Ablation of Malignant Liver Lesions. Cancers (Basel). 2025;17 (8):. doi: 10.3390/cancers17081264. PubMed PMID:40282440 PubMed Central PMC12025993.
  15. Che, H, Lyu, J, Xu, E, Wu, J. Optimization and evaluation of liver deformation modeling under microwave ablation based on ex vivo data. Phys Med Biol. 2025;70 (10):. doi: 10.1088/1361-6560/add07c. PubMed PMID:40273931 .
  16. Todeschini, L, Caimano, M, Mattia, A, Cristin, L, Martinino, A, Bianco, G et al.. Radiofrequency ablation versus surgical resection in colorectal liver metastasis: insight from an umbrella review. Front Oncol. 2025;15 :1494996. doi: 10.3389/fonc.2025.1494996. PubMed PMID:40255430 PubMed Central PMC12006127.
  17. Zhou, J, Qin, S, Cui, R, Chen, Y, Wang, Y, Liu, G et al.. Outcomes of ultrasound-guided percutaneous ablation of >5 versus ≤ 5 colorectal liver metastases: a propensity score matching study. Int J Hyperthermia. 2025;42 (1):2488128. doi: 10.1080/02656736.2025.2488128. PubMed PMID:40255153 .
  18. Katsouda, A, Markou, M, Valakos, D, Theodorou, I, Papapetropoulos, A. Cth/Mpst double ablation results in early onset fatty liver disease in lean mice. Redox Biol. 2025;83 :103641. doi: 10.1016/j.redox.2025.103641. PubMed PMID:40253747 PubMed Central PMC12023873.
  19. Li, B, Li, L, Ren, H. Surgical Resection Versus Microwave Ablation for Colorectal Liver Oligometastases: A Multicenter Cohort Study of 1027 Patients. J Gastrointest Cancer. 2025;56 (1):101. doi: 10.1007/s12029-025-01222-y. PubMed PMID:40244487 PubMed Central PMC12006233.
  20. Lu, H, Xie, X, Zeng, Y, Xia, X, Dong, X, Bu, F et al.. Prognostic Comparison of Complete vs. Incomplete Radiofrequency Ablation for Colorectal Liver Metastases: A Multicenter Prospective Study. Cancer Med. 2025;14 (8):e70735. doi: 10.1002/cam4.70735. PubMed PMID:40231586 PubMed Central PMC11997704.
Search PubMed
Posted on

Renal ablation articles

  1. Tahmasebi, A, Siu Xiao, T, Wessner, CE, Kuon Yeng Escalante, CM, Lyshchik, A, Forsberg, F et al.. Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation Surveillance. Ultrasound Med Biol. 2025; :. doi: 10.1016/j.ultrasmedbio.2025.04.021. PubMed PMID:40436663 .
  2. Islamuddin, M, Evangelista, J, Kabir, ME, Vidal, AKN, Liu, S, Qin, X et al.. Rapid Depletion of Renal Macrophages using Human CD59/Intermedilysin Cell Ablation Tool. J Vis Exp. 2025; (219):. doi: 10.3791/67957. PubMed PMID:40418671 .
  3. Garofano, G, Saitta, C, Musso, G, Meagher, MF, Capitanio, U, Puri, D et al.. Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablation. Urol Oncol. 2025; :. doi: 10.1016/j.urolonc.2025.04.012. PubMed PMID:40413064 .
  4. Stouvenot, M, Koch, S, Frontzcak, A, D'Engremont, C, Boinette, A, Doussot, A et al.. Effectiveness and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic metastases of renal cell carcinoma. Endosc Int Open. 2025;13 :a25667350. doi: 10.1055/a-2566-7350. PubMed PMID:40376026 PubMed Central PMC12080524.
  5. Smits, MLJ, Wijnen, N, Bruijnen, RCG, Brinkman, WM, Willemse, PM, Ramdhani, K et al.. Renal Arteriography and C-arm CT-Guided Ablation (RenACAGA) for Thermal Ablation of Challenging Renal Tumors. Cardiovasc Intervent Radiol. 2025; :. doi: 10.1007/s00270-025-04039-1. PubMed PMID:40295401 .
  6. Kim, J, Uy, M, Cheng, A, Syed, L, Almuaiqel, M, Matsumoto, E et al.. Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up. J Endourol. 2025; :. doi: 10.1089/end.2024.0849. PubMed PMID:40274368 .
  7. Koike, Y, Motohashi, K, Kuwabara, N, Miyauchi, T, Okada, M. Radiofrequency ablation of renal tumour in the supine position using a dorsal-space mat. BJR Case Rep. 2025;11 (2):uaaf025. doi: 10.1093/bjrcr/uaaf025. PubMed PMID:40270552 PubMed Central PMC12017616.
  8. Borghi, C, Bragagni, A. In these cases, I treat hypertension with renal ablation. Eur Heart J Suppl. 2025;27 (Suppl 3):iii32-iii35. doi: 10.1093/eurheartjsupp/suaf012. PubMed PMID:40248286 PubMed Central PMC12001763.
  9. Fisher, G, Kaufman, H, Wilcox, A, Torralba, E, Boldman, E, Boyer, B et al.. Percutaneous Microwave Ablation of Small (<4 cm) Renal Masses Performed under Moderate Sedation. J Vasc Interv Radiol. 2025; :. doi: 10.1016/j.jvir.2025.03.024. PubMed PMID:40209844 .
  10. Gonçalves, OR, de Melo Neto, AP, Machado Pereira, MAO, Ohannesian, VA, Fernandes, MAN, Dantas, CR et al.. Renal denervation plus cardiac ablation vs. cardiac ablation alone for patients with atrial fibrillation and uncontrolled arterial hypertension : A systematic review and updated meta-analysis of randomized controlled trials. Herz. 2025; :. doi: 10.1007/s00059-025-05302-4. PubMed PMID:40204910 .
  11. Pickersgill, NA. Editorial Comment on "A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER)". Urology. 2025;200 :125-126. doi: 10.1016/j.urology.2025.04.003. PubMed PMID:40204106 .
  12. Torres, TP, Liakopoulos, I, Balomenos, V, Grigoriadis, S, Papakonstantinou, O, Kelekis, N et al.. Adjunctive techniques for renal cell carcinoma ablation: an update. Front Radiol. 2025;5 :1559411. doi: 10.3389/fradi.2025.1559411. PubMed PMID:40165795 PubMed Central PMC11955682.
  13. Askarpour, M, Aminsharifi, A. Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation. Cancers (Basel). 2025;17 (6):. doi: 10.3390/cancers17060974. PubMed PMID:40149308 PubMed Central PMC11940802.
  14. Chan, VW, Ng, HH, Abdulrauf, K, Zaman, H, Ahmed, A, Zhong, J et al.. Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments. Medicina (Kaunas). 2025;61 (3):. doi: 10.3390/medicina61030438. PubMed PMID:40142250 PubMed Central PMC11943572.
  15. Baer, BR, Matheny, MV, Mercedes, RH, Raman, JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Curr Oncol. 2025;32 (3):. doi: 10.3390/curroncol32030125. PubMed PMID:40136329 PubMed Central PMC11940996.
  16. Travesso, DJ, de Melo, RAB, Almeida, MFA, Motta-Leal-Filho, JM, Moura, EBS, Machado, F et al.. T1b Renal Masses Radiofrequency Ablation: Feasibility, Safety, and Efficacy in Midterm Follow-Up. Int J Urol. 2025;32 (6):764-766. doi: 10.1111/iju.70042. PubMed PMID:40062605 .
  17. Cassim, R, Bansal, R, Millan, B, Mironov, O, Ahir, P, Tajzler, C et al.. A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER). Urology. 2025;200 :118-124. doi: 10.1016/j.urology.2025.02.053. PubMed PMID:40058468 .
  18. Schaarschmidt, BM, Zensen, S, Kesch, C, Dertnig, T, Opitz, M, Drews, M et al.. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy. Eur Radiol. 2025;35 (3):1723-1731. doi: 10.1007/s00330-024-11343-w. PubMed PMID:40016555 PubMed Central PMC11868359.
  19. Carbonara, U, Ditonno, F, Beksac, AT, Derweesh, I, Cerrato, C, Celia, A et al.. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025;51 (2):. doi: 10.1590/S1677-5538.IBJU.2024.0565. PubMed PMID:39913094 PubMed Central PMC11884627.
  20. Wells, SA, Shapiro, D, Borza, T, Allen, G, Hinshaw, JL, Ziemlewicz, TJ et al.. Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04794-8. PubMed PMID:39912925 .
Search PubMed